Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2400007	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSZ1900037	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2019-07-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-02	view
CXSL2000306	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products(2.4)	New Drug Application	2020-10-28	成都蓉生药业有限责任公司	Chengdu Rongsheng Pharmaceuticals Co Ltd	In Review	2020-10-27	view
JYSB2300059	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB1800153	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2018-08-02	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2018-10-30	view
JYSB2101206	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB1700198	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2017-11-14	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2017-12-04	view
JYSB2000201	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-05-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-29	view
JYSB2300061	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB1800090	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2018-05-07	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2018-06-29	view
JYSB2101207	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view
JYSB1600286	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2017-01-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2017-03-15	view
JYSZ2400008	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2024-01-13					view
JYSZ1900036	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	License Renew	2019-07-05	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-02	view
JYSB2000200	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2020-05-20	丹麦诺和诺德公司	Novo Nordisk A/S	Filed	2020-05-29	view
JYSB0500009	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2005-03-25	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2005-12-26	view
JYSB2300060	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2023-04-05		Novo Nordisk A/S			view
JYSB1800089	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2018-05-07	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2018-06-29	view
CXSL2000034	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products(10)	New Drug Application	2020-02-27	正大天晴药业集团股份有限公司	Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd	In Review	2020-02-26	view
JYSB2101208	注射用重组人凝血因子Ⅶa	Recombinant Coagulation Factor Ⅶa	Lyophilized	Biological Products	Supplementary Application	2021-12-23		Novo Nordisk A/S			view